Prescription Justice

Taking on the Crisis of High Drug Prices in America

[Prescription Justice @rxjusticegroup]

Prescription Justice president Gabriel Levitt joined @McGrawMilhaven on America at Night to discuss how a new CBP rule could disrupt Americans’ access to lower-cost prescription drugs imported for personal use. Listen here: https://t.co/et7p3rt5m6

[Prescription Justice @rxjusticegroup]

Prescription Justice warns that a new CBP rule could make it harder for Americans to import affordable prescription medicines for personal use. FDA and CBP must protect patients while targeting unsafe drugs. Learn more:
https://t.co/FADdH2v6wT

[Prescription Justice @rxjusticegroup]

@PORTAL_Research @SSWorks @P4AD_

[Prescription Justice @rxjusticegroup]

Congress gave FDA direction on personal prescription drug importation >20 years ago. With millions of Americans unable to afford prescription drugs, it’s time to give § 804(j)(1) its due. New from PJ President Gabriel Levitt in @pennlaw @TheRegReview: https://t.co/9j49qDp7KS

[Prescription Justice @rxjusticegroup]

🎉Big win for lower drug prices!
Prescription Justice congratulates #Colorado on receiving FDA approval for its Canadian wholesale prescription drug #importation program, now the 2nd state to move forward. Full statement: [https://t.co/rPjDwwQ7mW]

[CAPD @RxDrugCoalition]

"Transparency reforms are popular as a bipartisan solution to mitigate drug costs, they do little for individual beneficiaries… it may also have the unintended consequence of ... pressuring competing PBMs to align their payment amounts to pharmacies" @AAF https://t.co/Um9RXujQH2

[CSRxP @RxPricing]

ICYMI: When the three #BigPharma giants who dominate the #insulin market were asked to rule out future #insulin price hikes, all three refused or caveated their answers to allow room to price-gouge patients in the future. Hold them accountable. @sanofi @novonordisk @EliLillyandCo

[CAPD @RxDrugCoalition]

“PBMs help deliver savings to patients by negotiating the prices that pharmacies get reimbursed for prescription medicines. In addition, they frequently utilize contracting to help reduce costs,” – @taxreformer. More: https://t.co/LNbs5UYNae

[Prescription Justice @rxjusticegroup]

💊New poll shows 1/3 of Americans have not filled prescriptions due to high costs.

[Prescription Justice @rxjusticegroup]

✅ New bill approved to force PBMs to have more transparency; they are a main cause for rising drug prices.

[Patients For Affordable Drugs NOW @P4ADNOW]

“We urge the Senate to immediately act on legislation to lower drug prices through increased competition, transparency, and accountability.” Letter here → https://t.co/mtUfADMQSC

[Prescription Justice @rxjusticegroup]

🚨New proposal alert! Learn about the SMART Prices Act proposed by Senators @amyklobuchar and @PeterWelch

[Prescription Justice @rxjusticegroup]

👎🏼The FDA and Big Pharma's new decision will hurt millions of Americans who are seeking to afford their life-saving medications. Here is a policy recommendation for the FDA based on Congress.

[CAPD @RxDrugCoalition]

Pharmacy benefits save patients millions each year. Over the next decade, they’ll save government programs $445 billion. Tell lawmakers to halt legislation that will restrict pharmacy benefits: https://t.co/dFpn2Gnm4f

[CAPD @RxDrugCoalition]

Big Pharma accumulates patents to protect their profits and keep more affordable generic and biosimilar competition off the market. Read @Alex_BrillDC’s report about the billion-dollar cost of Big Pharma’s tactics: https://t.co/B0Cn2955mo

[Prescription Justice @rxjusticegroup]

❓What improvements were recently made to Medicare Advantage Plans and how do they help lower prescription drug prices?

[T1International @t1international]

Although insulin manufacturers are making steps in the right direction, lowered costs for some insulins are only quick fixes. They need to be held to account, with insulin prices controlled to ensure prices don't increase again. Click here for more info: https://t.co/o6XJDY56r4

[David Mitchell @DavidP4AD]

Fact: PBMs’ interests are not aligned with lower drug prices.
“Higher prices put more dollars into a PBM’s pockets,” said professsor @ProfRobnFeldman.
Join us at https://t.co/MnYDxEDor5. We intend to win reforms that ensure PBMs serve patients.
https://t.co/yNuXMM0U8A

[CSRxP @RxPricing]

DYK: A recent poll found that more than 1/3 of patients couldn’t fill their #prescription medications because the price was too high. It’s time to hold #BigPharma accountable for their patent abuse that keeps #drugprices high.

Read the full report:
https://t.co/D4UhnJXmeV

[David Mitchell @DavidP4AD]

The Problem With PBMs:
Abiraterone is generic, yet the average cost to Medicare per month is $3,000. Civica sells the drug for around $160, but try as they might, Civica cannot get PBMs to buy abiraterone.
PBMs prefer the higher price; patients pay.
https://t.co/JyEDq90cYC